You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 1, January 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (71)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Short-Wavelength Automated Perimetry in Low-, Medium-, and High-Risk Ocular Hypertensive Eyes

Initial Baseline Results

Chris A. Johnson, PhD; James D. Brandt, MD; Anne M. Khong, MD; Anthony J. Adams, OD, PhD

Arch Ophthalmol. 1995;113(1):70-76.


Abstract

Objective
To examine the relationship between the prevalence of short-wavelength sensitivity losses in the central 30° visual field and risk factors for development of glaucomatous visual field loss in ocular hypertension.

Design
A modified Humphrey Field Analyzer was used to perform standard automated perimetry and short-wavelength automated perimetry (SWAP), which is a technique that isolates the activity of short-wavelength—sensitive ("blue") mechanisms. In addition, an assessment of the risk of developing glaucomatous visual field loss was determined, based on a validated model that utilized intraocular pressure, a family history of glaucoma, age, and the vertical cup-to-disc ratio.

Patients
Both eyes of 232 ocular hypertensive patients were examined and compared with results from an age-matched control group of normal subjects. Both ocular hypertensive patients and normal subjects had to have normal visual fields on standard automated perimetry, good visual acuity, and no evidence of other ocular or neurologic disease or surgery. Intraocular pressure in the ocular hypertensive patients was 21 mm Hg or greater OU (without medication), and it was less than 20 mm Hg OU in normal control subjects.

Results
Less than 10% of the low-risk ocular hypertensive eyes had a SWAP deficit, as compared with 20% of the moderate-risk and 33% of the high-risk ocular hypertensive eyes. Intraocular pressure and a family history of glaucoma showed no meaningful relationship with the prevalence of SWAP deficits, but both age and the vertical cup-to-disc ratio demonstrated a strong association with the SWAP abnormalities.

Conclusions
The SWAP results that were found in the ocular hypertensive eyes were associated with other risk factors that have been reported to be predictive of the development of glaucomatous visual field loss, especially the vertical cup-to-disc ratio and age. These findings support the notion that the SWAP deficits represent early glaucomatous damage and may be related to early changes that occur at the optic nerve head.



Author Affiliations

From the Optics and Visual Assessment Laboratory, Department of Ophthalmology, School of Medicine, University of California, Davis (Drs Johnson, Brandt, and Khong), and the School of Optometry, University of California, Berkeley (Dr Adams). The authors have no proprietary interest in the methods, devices, or products that were used as part of this research project.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diffuse Glaucomatous Structural and Functional Damage in the Hemifield Without Significant Pattern Loss
Grewal et al.
Arch Ophthalmol 2009;127:1442-1448.
ABSTRACT | FULL TEXT  

Comparing the Full-Threshold and Swedish Interactive Thresholding Algorithms for Short-Wavelength Automated Perimetry
Ng et al.
IOVS 2009;50:1726-1733.
ABSTRACT | FULL TEXT  

Visual Function-Specific Perimetry to Identify Glaucomatous Visual Loss Using Three Different Definitions of Visual Field Abnormality
Tafreshi et al.
IOVS 2009;50:1234-1240.
ABSTRACT | FULL TEXT  

Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry.
Bagga et al.
Arch Ophthalmol 2006;124:169-176.
ABSTRACT | FULL TEXT  

Short wavelength automated perimetry in age related maculopathy
Remky et al.
Br J Ophthalmol 2001;85:1432-1436.
ABSTRACT | FULL TEXT  

Long-term Fluctuation in Short-Wavelength Automated Perimetry in Glaucoma Suspects and Glaucoma Patients
Hutchings et al.
IOVS 2001;42:2332-2337.
ABSTRACT | FULL TEXT  

Comparison of Conventional and Pattern Discrimination Perimetry in a Prospective Study of Glaucoma Patients
Ansari et al.
IOVS 2000;41:4150-4157.
ABSTRACT | FULL TEXT  

Visual Function-Specific Perimetry for Indirect Comparison of Different Ganglion Cell Populations in Glaucoma
Sample et al.
IOVS 2000;41:1783-1790.
ABSTRACT | FULL TEXT  

Achromatic and Short-Wavelength Automated Perimetry in Patients With Glaucomatous Large Cups
Mansberger et al.
Arch Ophthalmol 1999;117:1473-1477.
ABSTRACT | FULL TEXT  

Short-Wavelength Automated Perimetry and Retinal Nerve Fiber Layer Evaluation in Suspected Cases of Glaucoma
Polo et al.
Arch Ophthalmol 1998;116:1295-1298.
ABSTRACT | FULL TEXT  

Impaired motion sensitivity as a predictor of subsequent field loss in glaucoma suspects: the Roscommon Glaucoma Study
Wu et al.
Br J Ophthalmol 1998;82:534-537.
ABSTRACT | FULL TEXT  

Short-Wavelength Automated Perimetry and Motion Automated Perimetry in Patients With Glaucoma
Sample et al.
Arch Ophthalmol 1997;115:1129-1133.
ABSTRACT  

Early Diagnosis of Functional Damage in Patients With Glaucoma
Caprioli
Arch Ophthalmol 1997;115:113-114.
ABSTRACT  

Short-Wavelength Automated Perimetry in Neuro-ophthalmologic Disorders
Keltner and Johnson
Arch Ophthalmol 1995;113:475-481.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.